STAR and polycystic ovary syndrome: In other PCOS groups that received separate or concurrent injections of OX1Ra, OX2Ra, and NK1Ra, increased Star expression and decreased Cyp19a1 expression were observed when compared to the PCOS control group, but these changes were negligible.